Evidence map›Paper›PMID 22752156›Full record

ReviewCellular and molecular life sciences : CMLS2013

Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy.

SongTing Shi, David J J de Gorter, Willem M H Hoogaars, Peter A C 't Hoen, Peter ten Dijke

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Modeling theeLife · 2021
    Article
  10. Review
  11. Article
  12. A comparison of the bone and growth phenotype ofDisease models & mechanisms · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Location-dependent heterotopic ossification in the rat model: The role of activated matrix metalloproteinase 9.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2016
    Article
  18. Immune-mediated pathology in Duchenne muscular dystrophy.Science translational medicine · 2015
    Review
  19. Article
  20. Interaction between Muscle and Bone.Journal of bone metabolism · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

SongTing ShiDepartment of Molecular Cell Biology and Centre for Biomedical Genetics, Leiden University Medical Centre, Building 2, Room R-02-022, Postzone S-1-P, PO Box 9600, Einthovenweg 20, 2300 RC, Leiden, The Netherlands.
David J J de Gorter
Willem M H Hoogaars
Peter A C 't Hoen
Peter ten Dijke
Leiden University Medical Center · NLUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone morphogenetic proteins (BMPs) are important extracellular cytokines that play critical roles in embryogenesis and tissue homeostasis. BMPs signal via transmembrane type I and type II serine/threonine kinase receptors and intracellular Smad effector proteins. BMP signaling is precisely regulated and perturbation of BMP signaling is connected to multiple diseases, including musculoskeletal diseases. In this review, we will summarize the recent progress in elucidation of BMP signal transduction, how overactive BMP signaling is involved in the pathogenesis of heterotopic ossification and Duchenne muscular dystrophy, and discuss possible therapeutic strategies for treatment of these diseases.

Indexed as

Bone Morphogenetic Protein Receptors, Type IBone Morphogenetic Protein Receptors, Type IIBone Morphogenetic ProteinsHumansMuscular Dystrophy, DuchenneOssification, HeterotopicSignal TransductionBone Morphogenetic Protein Receptors, Type IBone Morphogenetic Protein Receptors, Type IIBone Morphogenetic Proteins

Identifiers

PMID22752156
PMCPMC3541930
OpenAlexW2046270293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.